Menopause International > Volume 14, Number 1 > Pp. 38-39

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Price, M. D. Articles by Shulman, L. M Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Clinical practice

Management of Parkinson's disease in older women

Molly Daymont Price and Lisa M Shulman

Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA

Correspondence: Dr Lisa M Shulman, Associate Professor of Neurology, Department of Neurology, University of Maryland School of Medicine, 22 S Greene Street, N4W46, Baltimore, MD 21201, USA. Email: lshulman{at}som.umaryland.edu
Elderly women with Parkinson's disease (PD) represent a specific patient population that may benefit from individualized treatment strategies. PD has been shown to occur approximately twice as often in men than in women, resulting in theories regarding estrogen being protective against the disease and as a potential treatment strategy. Given women's longer life expectancy, they are more likely to reach an age where antiparkinsonian medications are associated with side-effects. This paper will review medical and surgical treatments as well as the relationship of gender and age with respect to the management of PD.

Key Words: Parkinson's disease • ageing • women • estrogen • levodopa

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?